Alterations in the p85 regulatory subunit of PI3K due to mutations can lead to constitutive hyperactive PI3K/Akt signaling and this genetic alteration is relatively uncommon in breast cancer (2.8% in the TCGA database) [151]. This evidence concerns the gene AKT1 and breast cancer.